Geneva Advisors’s Dentsply Sirona XRAY Stock Holding History
Bought
Maintained
Sold
Other funds holding XRAY
RCG
VAM
Geneva Advisors's XRAY Position: Q2 2017 in Review
Geneva Advisors increased its Dentsply Sirona (XRAY) stake by 711% in Q2 2017, buying an estimated $34.3M and bringing the position to 619,344 shares worth $40.2M. The position accounts for 0.69% of the portfolio, ranked #50.
Geneva Advisors first reported a position in XRAY in Q3 2016 and has held it in 4 quarters since. 548 funds tracked by Wall St. Rank hold XRAY as of Q2 2017.
- Geneva Advisors held 619,344 shares of Dentsply Sirona worth $40.2M as of Q2 2017.
- Geneva Advisors bought 542,982 Dentsply Sirona shares in Q2 2017, an estimated $34.3M.
- Dentsply Sirona made up 0.69% of Geneva Advisors's portfolio in Q2 2017, its #50 holding.
- Geneva Advisors first reported a position in Dentsply Sirona in Q3 2016 and has held it in 4 quarters since.
- 548 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2017.
Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.